The Tommy Dreamer creative era in TNA is now over. Dreamer had been the lead member of the TNA creative team since 2024, taking over in that spot after Scott D'Amore left the company. Dreamer ...

There has been a wind of change blowing through one particular wrestling promotion over the last month, with multiple TNA wrestlers departing after asking for and receiving their releases. Now change ...

It has been a whirlwind of a week for TNA Wrestling and those behind-the-scenes, after it was revealed Wednesday by the company that it was going through "workforce reduction," leading to the ...

The Jscrambler client-side web security company disclosed that a threat actor published a malicious version of its npm ...

While last week's TNA departure of Tommy Dreamer was said by both parties to be a mutual decision, there's now a little more information on Dreamer's TNA exit. To circle back to Tommy Dreamer, a new ...

JFrog finds 148 npm proxy packages turned student browsers into a DDoS botnet, while a mutable loader lets operators re-arm ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

JetBrains seeks to unify fragmented AI-based software development with governance suite The new suite will help developers reduce operational friction and help enterprise leaders with governance, cost ...

Tommy Dreamer and TNA Wrestling mutually parted ways last week. Now the wrestling legend is facing a wide range of allegations from multiple pro wrestlers. Dreamer left his role in TNA creative last ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

If you receive JavaScript required to sign in error message when using Skype, OneDrive, Teams or any other program, you need to turn on or enable JavaScript in your ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by ...